Suppr超能文献

大黄蒽醌类化合物的抗癌特性

Anti-cancer properties of anthraquinones from rhubarb.

作者信息

Huang Qing, Lu Guodong, Shen Han-Ming, Chung Maxey C M, Ong Choon Nam

机构信息

Department of Community, Occupational and Family Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

出版信息

Med Res Rev. 2007 Sep;27(5):609-30. doi: 10.1002/med.20094.

Abstract

Rhubarb has been used as a traditional Chinese medicine since ancient times and today it is still present in various herbal preparations. In this review the toxicological and anti-neoplastic potentials of the main anthraquinones from Rhubarb, Rheum palmatum, will be highlighted. It is interesting to note that although the chemical structures of various anthraquinones in this plant are similar, their bioactivities are rather different. The most abundant anthraquinone of rhubarb, emodin, was capable of inhibiting cellular proliferation, induction of apoptosis, and prevention of metastasis. These capabilities are reported to act through tyrosine kinases, phosphoinositol 3-kinase (PI3K), protein kinase C (PKC), NF-kappa B (NF-kappaB), and mitogen-activated protein kinase (MAPK) signaling cascades. Aloe-emodin is another major component in rhubarb found to have anti-tumor properties. Its anti-proliferative property has been demonstrated to be through the p53 and its downstream p21 pathway. Our recent proteomic study also suggests that the molecular targets of these two anthraquinones are different. However, both components were found to be able to potentiate the anti-proliferation of various chemotherapeutic agents. Rhein is the other major rhubarb anthraquinone, although less well studied. This compound could effectively inhibit the uptake of glucose in tumor cells, caused changes in membrane-associated functions and led to cell death. Interestingly, all three major rhubarb anthraquinones were reported to have in vitro phototoxic. This re-evaluation of an old remedy suggests that several bioactive anthraquinones of rhubarb possess promising anti-cancer properties and could have a broad therapeutic potential.

摘要

大黄自古以来就被用作中药,如今仍存在于各种草药制剂中。在本综述中,将重点介绍掌叶大黄中主要蒽醌类化合物的毒理学和抗肿瘤潜力。值得注意的是,尽管该植物中各种蒽醌类化合物的化学结构相似,但其生物活性却有很大差异。大黄中含量最丰富的蒽醌类化合物大黄素,能够抑制细胞增殖、诱导细胞凋亡并预防转移。据报道,这些作用是通过酪氨酸激酶、磷脂酰肌醇3激酶(PI3K)、蛋白激酶C(PKC)、核因子κB(NF-κB)和丝裂原活化蛋白激酶(MAPK)信号级联反应来实现的。芦荟大黄素是大黄中另一种具有抗肿瘤特性的主要成分。其抗增殖特性已被证明是通过p53及其下游的p21途径实现的。我们最近的蛋白质组学研究还表明,这两种蒽醌类化合物的分子靶点不同。然而,发现这两种成分都能够增强各种化疗药物的抗增殖作用。大黄酸是大黄中另一种主要的蒽醌类化合物,尽管对其研究较少。该化合物能有效抑制肿瘤细胞对葡萄糖的摄取,引起膜相关功能的变化并导致细胞死亡。有趣的是,据报道大黄的所有三种主要蒽醌类化合物在体外都具有光毒性。对这种古老药物的重新评估表明,大黄中的几种生物活性蒽醌类化合物具有良好的抗癌特性,可能具有广泛的治疗潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验